Joseph W Windsor1,2, Gilaad G Kaplan3,4. 1. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Teaching Research and Wellness Building 3D03-18, 3280 Hospital Drive NW, Calgary, Alberta, T2N 4Z6, Canada. 2. Department of Medicine, Cumming School of Medicine, University of Calgary, Teaching Research and Wellness Building 3D03-18, 3280 Hospital Drive NW, Calgary, Alberta, T2N 4Z6, Canada. 3. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Teaching Research and Wellness Building 3D03-18, 3280 Hospital Drive NW, Calgary, Alberta, T2N 4Z6, Canada. ggkaplan@ucalgary.ca. 4. Department of Medicine, Cumming School of Medicine, University of Calgary, Teaching Research and Wellness Building 3D03-18, 3280 Hospital Drive NW, Calgary, Alberta, T2N 4Z6, Canada. ggkaplan@ucalgary.ca.
Abstract
PURPOSE OF REVIEW: Once thought a disease of Western civilizations, the inflammatory bowel diseases (IBD) impose a global burden, now penetrating populations in Asia, Africa, and South America. We summarize similarities and differences in the epidemiology of IBD globally, highlighting gaps in knowledge where future study is needed. RECENT FINDINGS: While incidence of IBD is stabilizing (or even decreasing) in many westernized regions, prevalence continues to grow due to a young age of onset and low mortality. In newly westernized regions, IBD is beginning to penetrate populations comparable to the rapid increases seen in North America, Europe, and Oceania in the last century. IBD imposes a significant fiscal and resource burden on healthcare systems. As global prevalence of these diseases continues to increase, we desperately need to anticipate the future burden to proactively prepare our healthcare systems for the challenges of increased patient load and aging populations with comorbid conditions and longer disease course.
PURPOSE OF REVIEW: Once thought a disease of Western civilizations, the inflammatory bowel diseases (IBD) impose a global burden, now penetrating populations in Asia, Africa, and South America. We summarize similarities and differences in the epidemiology of IBD globally, highlighting gaps in knowledge where future study is needed. RECENT FINDINGS: While incidence of IBD is stabilizing (or even decreasing) in many westernized regions, prevalence continues to grow due to a young age of onset and low mortality. In newly westernized regions, IBD is beginning to penetrate populations comparable to the rapid increases seen in North America, Europe, and Oceania in the last century. IBD imposes a significant fiscal and resource burden on healthcare systems. As global prevalence of these diseases continues to increase, we desperately need to anticipate the future burden to proactively prepare our healthcare systems for the challenges of increased patient load and aging populations with comorbid conditions and longer disease course.
Entities:
Keywords:
Burden of disease; Crohn’s disease; Epidemiology; Global health; Inflammatory bowel disease; Ulcerative colitis
Authors: Stefan Begré; Benjamin Misselwitz; Sebastian Bruno Ulrich Jordi; Brian Matthew Lang; Jacqueline Wyss; Bianca Auschra; Bahtiyar Yilmaz; Niklas Krupka; Thomas Greuter; Philipp Schreiner; Luc Biedermann; Martin Preisig; Roland von Känel; Gerhard Rogler Journal: J Gastroenterol Date: 2022-07-28 Impact factor: 6.772
Authors: Ayano Kondo; Siyuan Ma; Michelle Y Y Lee; Vivian Ortiz; Daniel Traum; Jonathan Schug; Benjamin Wilkins; Natalie A Terry; Hongzhe Lee; Klaus H Kaestner Journal: Gastroenterology Date: 2021-09-14 Impact factor: 22.682